Annovis Bio Announces $21 Million Public Offering of Common Shares and Warrants
Annovis Bio (ANVS) has priced an underwritten public offering consisting of 19 million common shares and pre-funded warrants for up to 2 million additional shares. The deal is set at a combined price of $1.00 per share. In addition to the primary shares, the offering includes accompanying warrants that allow for the purchase of up to 21 million more common shares. Following the announcement of the dilutive financing, the company's stock experienced a significant decline in value.
Tickers: $ANVS
Topics: Capital Raising Public Offering Warrants